Sweden· SE-19690529000018
Tavegyl 1 mg Tablett
A medicinal product containing clemastine, registered in Sweden by STADA Arzneimittel AG.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Clemastine
- Manufacturer
- STADA Arzneimittel AG
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer19690529000018
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Clemastine in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsClemastine TioFarma 1 mg, tablettenTiofarma B.V.
- NorwayTavegylCentrafarm
- PolandClemastinum HascoPrzedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
- United KingdomTavegil 1mg tabletsThornton & Ross Ltd
- IcelandTavegylSTADA Arzneimittel AG
- Japanクレマスチンフマル酸塩日医工
- GermanyTavegilStada Gmbh
- United StatesClemastine FumarateGenus Lifesciences
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Germany · Tavegil, Tavegil Tabletten
- Denmark · Clemastine Macure
- Estonia · Tavegyl
- Finland · Clemastine Macure
- United Kingdom (Northern Ireland) · Tavegil
- Iceland · Tavegyl
- Lithuania · Clemastinum Pph, Tavegyl
- Latvia · Tavegyl
- Netherlands · Clemastine Macure, Clemastine Milstein
- Norway · Clemastine Macure
- Poland · Clemastinum Aflofarm, Clemastinum Hasco
- Portugal · Tavégyl, Tavist
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/36135b97-c54a-4b7e-a2e2-8fb1273f350d GET /v1/drugs/36135b97-c54a-4b7e-a2e2-8fb1273f350d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC",
"Dispensbeslut"
],
"se_npl_id": "19690529000018",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=19690529000018",
"product_doc_link": "https://docetp.mpa.se/LMF/Tavegyl%20tablet%20SmPC_09001bee807a6d32.pdf"
}See everything about clemastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.